P-185 A prospective, randomized, controlled, multicenter phase III clinical trial of apatinib combined with neoadjuvant chemoradiotherapy for patients with locally advanced, HER2-negative, Siewert’s type II-III adenocarcinoma of esophagogastric junction
Titel:
P-185 A prospective, randomized, controlled, multicenter phase III clinical trial of apatinib combined with neoadjuvant chemoradiotherapy for patients with locally advanced, HER2-negative, Siewert’s type II-III adenocarcinoma of esophagogastric junction
Auteur:
Zhao, Q. Wang, J. Gou, H. Li, Y. Cheng, Y. Zhang, Z. Wang, D. Zhao, X. Liu, Y. Jing, S. Yang, P. Tian, Y. Liu, Y.